Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Interpace Diag Group (IDXG)

Interpace Diag Group (IDXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Interpace Diag Group WATERVIEW PLAZA SUITE 310 2001 ROUTE 46 PARSIPPANY NJ 07054 USA

www.interpace.com Employees: 111 P: 855-776-6419

Sector:

Medical

INDUSTRY GROUPING:

Medical Services

Description:

Interpace Biosciences Inc. is enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications. Its clinical services include molecular diagnostic tests, bioinformatics, and pathology services. Pharma services provide pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. Interpace Biosciences Inc., formerly known as INTERPACE DIAGN, is based in PARSIPPANY, NJ.

Key Statistics

Overview:

Market Capitalization, $K 6,189
Enterprise Value, $K 4,729
Shares Outstanding, K 4,420
Annual Sales, $ 46,930 K
Annual Net Income, $ 6,700 K
Last Quarter Sales, $ 8,760 K
Last Quarter Net Income, $ 910 K
EBIT, $ 5,580 K
EBITDA, $ 6,330 K
60-Month Beta 1.06
% of Insider Shareholders 5.50%
% of Institutional Shareholders 5.73%
Float, K 4,177
% Float 94.50%
Short Volume Ratio 0.06

Growth:

1-Year Return -54.35%
3-Year Return 40.00%
5-Year Return -59.18%
5-Year Revenue Growth 94.89%
5-Year Earnings Growth 107.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.04 on 11/12/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Qtr 133.33%
EPS Growth vs. Prev Year -87.10%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/15/20

IDXG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -380.23%
Return-on-Assets % 30.54%
Profit Margin % 14.28%
Debt/Equity 0.00
Price/Sales 0.14
Price/Cash Flow 0.87
Price/Book N/A
Book Value/Share -0.07
Interest Coverage 232.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar